A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.

Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients

NCT05559242 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function

NCT04993404 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

NCT04079790 ·Status: COMPLETED ·Phase: PHASE1

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment

NCT06674915 ·Status: COMPLETED ·Phase: PHASE1

GS1-144 in Participants With Hepatic Impairment and Healthy Female

NCT07491289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Pharmacokinetics of MCS in Healthy Volunteers

NCT01003171 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide

NCT05097716 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

NCT06888115 ·Status: COMPLETED ·Phase: PHASE1

A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects

NCT07076459 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

NCT05711797 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

NCT05581758 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions

NCT06399055 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

NCT06916169 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function

NCT02412098 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

NCT04536961 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects

NCT06684041 ·Status: COMPLETED ·Phase: PHASE1

Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

NCT05777109 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B

NCT01125657 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

NCT04116476 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

NCT06258746 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement

NCT06985615 ·Status: RECRUITING ·Phase: PHASE1

Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults

NCT04735913 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

NCT03826641 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet

NCT01125670 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib

NCT04772612 ·Status: COMPLETED ·Phase: PHASE1